ELUTE , INC.

FDA Approves Elute's BonVie+: A Novel Resorbable Bone Void Filler Addressing Limitations of Current Options

- Elute, Inc. has received FDA clearance for BonVie+, a calcium-salt resorbable bone void filler designed to overcome limitations of traditional bone cement and calcium sulfate-based alternatives. - The novel implant features controlled resorption technology that allows natural bone replacement over time, eliminating the need for additional removal surgeries common with non-biodegradable options. - BonVie+ represents over a decade of innovation in bone restoration technology and includes a kit system enabling surgeons to select appropriate granule sizes based on patient-specific anatomy in real time.